NLRP3 inflammasome activation is implicated in AD, Parkinson’s disease (PD), depression, anxiety, and diabetic complications, and it has been shown that inhibition of NLRP3 inflammasome activation can ameliorate these diseases [14,15,16,17]. This evidence concerns the gene NLRP3 and depressive symptom measurement.